Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
17.71
-0.24 (-1.34%)
Jul 24, 2025, 1:06 PM - Market open
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.44 billion as of July 24, 2025. Its market cap has increased by 83.50% in one year.
Market Cap
1.44B
Enterprise Value
851.05M
1-Year Change
83.50%
Ranking
Category
Stock Price
$17.67
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.44B, an increase of 4,054.84%. That is a compound annual growth rate of 39.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2025 | 1.46B | -3.55% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
| Jun 18, 2014 | 34.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.24B |
| Johnson & Johnson | 395.46B |
| AbbVie | 326.52B |
| Novo Nordisk | 286.26B |
| UnitedHealth Group | 255.94B |
| Novartis AG | 222.44B |
| Abbott Laboratories | 216.47B |
| AstraZeneca | 214.29B |